mass spectroscopy-based assay massarray system (Sequenom)
90
Structured Review
Sequenom
mass spectroscopy-based assay massarray system
Mass Spectroscopy Based Assay Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectroscopy-based+massarray/sequenom+massarray/us12365693-921-4-14
Average 90 stars, based on 1 article reviews
Mass Spectroscopy Based Assay Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectroscopy-based+massarray/sequenom+massarray/us12365693-921-4-14
Average 90 stars, based on 1 article reviews
mass spectroscopy-based assay massarray system - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Article Snippet: Objective: Insulin-like growth factor (IGF)-axis genes plays a critical role in cancer development and progression via their impact on the RAS/MAPK/ERK and PI3 K/AKT/mTOR signaling pathways.. We hypothesized that IGF-axis genetic variants modify individual susceptibility to pancreatic cancer.. Methods: We retrospectively genotyped 41 single-nucleotide polymorphisms of 10 IGF-axis genes (IGF1, IGF2, IGF1R, IGF2R, IGFBP1, IGFBP3, IGFBP5, IRS1, IRS2, and IRS4) in 706 pancreatic cancer patients and 706 cancer-free controls using Sequenom and TaqMan technology. Article Title: Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer Article Snippet: For genotyping, we used the Article Title: Insulin-like Growth Factor Axis Gene Polymorphisms and Clinical Outcome in Pancreatic Cancer Article Snippet: Genotyping used the mass spectroscopy-based MassArray (Sequenom, Inc, San Diego, CA) and the Taqman method. |